Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro

Area of Science:

• Immunology
• Cellular Biology
• Immunotherapy

Background:

• Thymosin alpha 1 (Tα1) is an immunomodulatory thymic peptide.
• Its precise impact on human CD8⁺ T-cell function requires further elucidation.

Purpose of the Study:

• To investigate Tα1's effects on CD8⁺ T-cell proliferation, activation, cytokine secretion, and exhaustion.
• To assess Tα1's potential role in modulating T-cell responses in vitro.

Main Methods:

• Human CD8⁺ T-cells were cultured under various conditions, including Tα1 and CD3/CD28 stimulation.
• Proliferation, activation markers (CD69, CD25, HLA-DR), exhaustion markers (PD-1, TIM-3, LAG-3), and cytokine secretion (IL-2, IFN-γ, TNF-α, IL-10) were analyzed.
• A T-cell exhaustion model was established using chronic stimulation prior to Tα1 treatment.

Main Results:

• Tα1 alone showed moderate increases in proliferation and activation.
• Combined Tα1 and CD3/CD28 stimulation significantly boosted proliferation and activation markers.
• Tα1 treatment reduced exhaustion markers (PD-1, TIM-3, LAG-3) in the exhaustion model.

Conclusions:

• Tα1 promotes CD8⁺ T-cell functional activation and mitigates exhaustion markers.
• Tα1 demonstrates potential as an adjunct in T-cell immunotherapies by enhancing activation and reversing exhaustion in vitro.